Vaccines, Blood & Biologics

Withdrawn - Draft Guidance for Industry: Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes

The guidance document entitled "Draft Guidance for Industry - Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes” was withdrawn on May 8, 2015.  Please visit: http://www.gpo.gov/fdsys/pkg/FR-2015-05-06/html/2015-10477.htm for additional information.
 

Page Last Updated: 05/08/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.